Annual Cash & Cash Equivalents:
$144.86M-$76.26M(-34.49%)Summary
- As of today, ANIP annual cash & cash equivalents is $144.86 million, with the most recent change of -$76.26 million (-34.49%) on December 31, 2024.
- During the last 3 years, ANIP annual cash & cash equivalents has risen by +$44.56 million (+44.43%).
- ANIP annual cash & cash equivalents is now -34.49% below its all-time high of $221.12 million, reached on December 31, 2023.
Performance
ANIP Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$271.50M+$47.95M(+21.45%)Summary
- As of today, ANIP quarterly cash & cash equivalents is $271.50 million, with the most recent change of +$47.95 million (+21.45%) on September 30, 2025.
- Over the past year, ANIP quarterly cash & cash equivalents has increased by +$118.19 million (+77.09%).
- ANIP quarterly cash & cash equivalents is now at all-time high.
Performance
ANIP Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ANIP Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -34.5% | +77.1% |
| 3Y3 Years | +44.4% | +382.4% |
| 5Y5 Years | +132.4% | +1416.8% |
ANIP Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -34.5% | +200.4% | at high | +410.0% |
| 5Y | 5-Year | -34.5% | +1742.1% | at high | +3352.5% |
| All-Time | All-Time | -34.5% | >+9999.0% | at high | >+9999.0% |
ANIP Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $271.50M(+21.5%) |
| Jun 2025 | - | $223.55M(+44.0%) |
| Mar 2025 | - | $155.22M(+2.7%) |
| Dec 2024 | $144.86M(-34.5%) | $151.20M(-1.4%) |
| Sep 2024 | - | $153.31M(-37.9%) |
| Jun 2024 | - | $247.05M(+3.7%) |
| Mar 2024 | - | $238.25M(+7.7%) |
| Dec 2023 | $221.12M(+358.5%) | $221.12M(+14.5%) |
| Sep 2023 | - | $193.08M(+19.4%) |
| Jun 2023 | - | $161.71M(+138.7%) |
| Mar 2023 | - | $67.76M(+27.3%) |
| Dec 2022 | $48.23M(-51.9%) | $53.23M(-5.4%) |
| Sep 2022 | - | $56.28M(-11.2%) |
| Jun 2022 | - | $63.38M(-17.6%) |
| Mar 2022 | - | $76.91M(-23.3%) |
| Dec 2021 | $100.30M(+1175.4%) | $100.30M(+557.5%) |
| Sep 2021 | - | $15.25M(-37.1%) |
| Jun 2021 | - | $24.26M(-3.2%) |
| Mar 2021 | - | $25.07M(+218.8%) |
| Dec 2020 | $7.86M(-87.4%) | $7.86M(-56.1%) |
| Sep 2020 | - | $17.90M(-35.4%) |
| Jun 2020 | - | $27.70M(+35.7%) |
| Mar 2020 | - | $20.41M(-67.2%) |
| Dec 2019 | $62.33M(+44.9%) | $62.33M(+4.5%) |
| Sep 2019 | - | $59.67M(+47.0%) |
| Jun 2019 | - | $40.59M(+6.2%) |
| Mar 2019 | - | $38.23M(-11.1%) |
| Dec 2018 | $43.01M(+38.1%) | $43.01M(-2.6%) |
| Sep 2018 | - | $44.14M(-19.7%) |
| Jun 2018 | - | $54.99M(+5.8%) |
| Mar 2018 | - | $51.97M(+66.9%) |
| Dec 2017 | $31.14M(+13.8%) | $31.14M(+72.7%) |
| Sep 2017 | - | $18.03M(+115.4%) |
| Jun 2017 | - | $8.37M(-22.7%) |
| Mar 2017 | - | $10.83M(-60.4%) |
| Dec 2016 | $27.36M(-82.3%) | $27.36M(+69.4%) |
| Sep 2016 | - | $16.16M(+7.6%) |
| Jun 2016 | - | $15.01M(-80.7%) |
| Mar 2016 | - | $77.75M(-49.7%) |
| Dec 2015 | $154.68M(-8.5%) | $154.68M(+2.5%) |
| Sep 2015 | - | $150.91M(-9.5%) |
| Jun 2015 | - | $166.73M(+0.7%) |
| Mar 2015 | - | $165.56M(-2.1%) |
| Dec 2014 | $169.04M(+1422.2%) | $169.04M(+382.3%) |
| Sep 2014 | - | $35.05M(-33.8%) |
| Jun 2014 | - | $52.96M(+3.1%) |
| Mar 2014 | - | $51.37M(+362.6%) |
| Dec 2013 | $11.11M(-68.1%) | $11.11M(-15.8%) |
| Sep 2013 | - | $13.19M(-11.2%) |
| Jun 2013 | - | $14.86M(-53.1%) |
| Mar 2013 | - | $31.65M(-9.0%) |
| Dec 2012 | $34.79M | $34.79M(-8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $38.05M(-10.3%) |
| Jun 2012 | - | $42.42M(-14.3%) |
| Mar 2012 | - | $49.47M(-13.5%) |
| Dec 2011 | $57.23M(+50.0%) | $57.23M(-17.8%) |
| Sep 2011 | - | $69.60M(+87.5%) |
| Jun 2011 | - | $37.13M(-27.7%) |
| Mar 2011 | - | $51.35M(+34.6%) |
| Dec 2010 | $38.16M(+27.8%) | $38.16M(+7.4%) |
| Sep 2010 | - | $35.53M(-23.4%) |
| Jun 2010 | - | $46.38M(+12.7%) |
| Mar 2010 | - | $41.16M(+37.9%) |
| Dec 2009 | $29.86M(+153.9%) | $29.86M(+126.7%) |
| Sep 2009 | - | $13.17M(+120.0%) |
| Jun 2009 | - | $5.99M(-41.1%) |
| Mar 2009 | - | $10.16M(-41.8%) |
| Dec 2008 | $11.76M(-24.8%) | - |
| Sep 2008 | - | $17.47M(-23.2%) |
| Jun 2008 | - | $22.76M(-17.5%) |
| Mar 2008 | - | $27.58M(-10.0%) |
| Dec 2007 | $15.65M(+104.5%) | $30.65M(+4.4%) |
| Sep 2007 | - | $29.36M(-6.2%) |
| Jun 2007 | - | $31.29M(+106.5%) |
| Mar 2007 | - | $15.15M(+32.3%) |
| Dec 2006 | $7.65M(+2364.2%) | $11.45M(+11.5%) |
| Sep 2006 | - | $10.27M(+128.0%) |
| Jun 2006 | - | $4.51M(-36.1%) |
| Mar 2006 | - | $7.05M(-22.5%) |
| Dec 2005 | $310.60K(-73.5%) | $9.10M(-11.6%) |
| Sep 2005 | - | $10.30M(-14.7%) |
| Jun 2005 | - | $12.07M(-30.1%) |
| Dec 2004 | $1.17M(-87.2%) | $17.27M(-16.1%) |
| Sep 2004 | - | $20.58M(-10.4%) |
| Jun 2004 | - | $22.97M(+178.0%) |
| Mar 2004 | - | $8.26M(-9.5%) |
| Dec 2003 | $9.13M(+87.0%) | $9.13M(-12.1%) |
| Sep 2003 | - | $10.40M(+345.2%) |
| Jun 2003 | - | $2.33M(-31.6%) |
| Mar 2003 | - | $3.41M(-35.1%) |
| Dec 2002 | $4.88M(+8.5%) | - |
| Sep 2002 | - | $5.26M(+208.4%) |
| Jun 2002 | - | $1.71M(-46.1%) |
| Mar 2002 | - | $3.16M(-29.7%) |
| Dec 2001 | $4.50M(+72.4%) | $4.50M(-24.7%) |
| Sep 2001 | - | $5.98M(+25.0%) |
| Jun 2001 | - | $4.78M(-8.4%) |
| Mar 2001 | - | $5.22M(+99.9%) |
| Dec 2000 | $2.61M(-50.5%) | $2.61M(-19.3%) |
| Sep 2000 | - | $3.23M(-3.9%) |
| Jun 2000 | - | $3.37M(-30.0%) |
| Mar 2000 | - | $4.81M |
| Dec 1999 | $5.27M(+85.6%) | - |
| Dec 1998 | $2.84M | - |
FAQ
- What is ANI Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for ANI Pharmaceuticals, Inc.?
- What is ANI Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is ANI Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for ANI Pharmaceuticals, Inc.?
- What is ANI Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is ANI Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of ANIP is $144.86M
What is the all-time high annual cash & cash equivalents for ANI Pharmaceuticals, Inc.?
ANI Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $221.12M
What is ANI Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, ANIP annual cash & cash equivalents has changed by -$76.26M (-34.49%)
What is ANI Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ANIP is $271.50M
What is the all-time high quarterly cash & cash equivalents for ANI Pharmaceuticals, Inc.?
ANI Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $271.50M
What is ANI Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, ANIP quarterly cash & cash equivalents has changed by +$118.19M (+77.09%)